Cite
HARVARD Citation
Ling, D. et al. (2013). The tellurium redox immunomodulating compound AS101 inhibits IL-1β-activated inflammation in the human retinal pigment epithelium. British journal of ophthalmology. 97 (7), pp. 934-938. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Ling, D. et al. (2013). The tellurium redox immunomodulating compound AS101 inhibits IL-1β-activated inflammation in the human retinal pigment epithelium. British journal of ophthalmology. 97 (7), pp. 934-938. [Online].